The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan starts giving 2nd dose of COVID vaccine for Omicron subvariant XBBTaiwan's Centers for Disease Control (CDC) on Tuesday began administering the second dose of the COVID-19 vaccine targeting the Omicron subvariant XBB to vulnerable groups.04/09/2024 10:26 PM
- Taiwan reports COVID-19 deaths in children after 10-month gapTaiwan reported two rare cases of COVID-19-related deaths in children ages 12 years and younger last week, breaking a 10-month streak without such fatalities, according to the Centers for Disease Control (CDC) on Tuesday.03/05/2024 08:20 PM
- CDC to expand eligibility for free flu jabs, urges COVID vaccinationMore people will be eligible to receive a government-funded free influenza vaccine shot from March 5, amid the growing spread of flu and COVID-19 in Taiwan, the Centers for Disease Control (CDC) said Friday.02/23/2024 07:03 PM
Latest
- Cross-Strait
KMT caucus whip heads to Beijing to discuss cross-strait ties
04/26/2024 06:24 PM - Sports
Rakuten Monkeys' renovated stadium opener postponed due to rain
04/26/2024 05:57 PM - Business
Gaming console industry gives Taiwan huge business opportunities: Tsai
04/26/2024 05:48 PM - Business
Taiwan's 2024 GDP growth forecast raised to 3.29% due to AI boom
04/26/2024 04:55 PM - Politics
Visiting Ukrainian NGOs call for more support from Taiwan
04/26/2024 04:48 PM